Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Osteoprotegerin / blood"'
Autor:
Sandra Makarović, Zorin Makarović, Ines Bilić-Ćurčić, Jasminka Milas-Ahić, Ivan Mihaljević, Maja Franceschi, Tomislav Jukić
Publikováno v:
Acta Clinica Croatica, Vol 56., Iss 4., Pp 733-741 (2017)
The aim of the study was to assess the role of serum osteoprotegerin (OPG) as a biomarker in patients with aortic valve stenosis (AS) in relation to heart failure and symptomatic status. This was a case control study, which included 51 patients with
Externí odkaz:
https://doaj.org/article/a4607e086cb74bbbb228a78c12c396d6
Autor:
Mette, Bjerre, Jørgen, Hilden, Jens, Kastrup, Maria, Skoog, Jørgen F, Hansen, Hans J, Kolmos, Gorm B, Jensen, Erik, Kjøller, Per, Winkel, Allan, Flyvbjerg, Christian, Gluud
Publikováno v:
Bjerre, M, Hilden, J, Kastrup, J, Skoog, M, Hansen, J F, Kolmos, H J, Jensen, G B, Kjøller, E, Winkel, P, Flyvbjerg, A, Gluud, C & Claricor Trial Group 2014, ' Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial ', Scandinavian journal of clinical and laboratory investigation, vol. 74, no. 8, pp. 657-64 . https://doi.org/10.3109/00365513.2014.930510
Bjerre, M, Hilden, J, Kastrup, J, Skoog, M, Hansen, J F, Kolmos, H J, Jensen, G B, Kjøller, E, Winkel, P, Flyvbjerg, A, Gluud, C & CLARICOR Trial Group 2014, ' Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease : The CLARICOR trial ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 74, no. 8, pp. 657-664 . https://doi.org/10.3109/00365513.2014.930510
Bjerre, M, Hilden, J, Kastrup, J, Skoog, M, Hansen, J F, Kolmos, H J, Jensen, G B, Kjøller, E, Winkel, P, Flyvbjerg, A, Gluud, C & CLARICOR Trial Group 2014, ' Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease : The CLARICOR trial ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 74, no. 8, pp. 657-664 . https://doi.org/10.3109/00365513.2014.930510
Objectives. To elucidate the prognostic power of serum osteoprotegerin (OPG) in patients with stable coronary artery disease (CAD). Methods. Serum OPG levels were measured in the CLARICOR trial cohort of 4063 patients with stable CAD on blood samples
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c2e8175f3a2ffa1cb653dbe9ab53ca4
Autor:
Cidália Pereira, Maria João Martins, Miguel Bernardes, Cecília Durães, Inês Brandão, Nuno Silva, Emanuel Passos, Rosário Monteiro, David Guede
Publikováno v:
Nutrients, Vol 11, Iss 10, p 2316 (2019)
Nutrients
Volume 11
Issue 10
Nutrients
Volume 11
Issue 10
Bone mineral density (BMD) and microstructure depend on estrogens and diet. We assessed the impact of natural mineral-rich water ingestion on distal femur of fructose-fed estrogen-deficient female Sprague Dawley rats. Ovariectomized rats drank tap or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5f371e810a4dfb299b58734ed1314ce
https://www.mdpi.com/2072-6643/11/10/2316
https://www.mdpi.com/2072-6643/11/10/2316
Autor:
Ines Bilic-Curcic, Zorin Makarović, Jasminka Milas-Ahić, Sandra Makarović, Ivan Mihaljević, Tomislav Jukić, Maja Franceschi
Publikováno v:
Acta Clinica Croatica, Vol 56, Iss 4, Pp 733-741 (2017)
The aim of the study was to assess the role of serum osteoprotegerin (OPG) as a biomarker in patients with aortic valve stenosis (AS) in relation to heart failure and symptomatic status. This was a case control study, which included 51 patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7132b7bef34f68f8316b9430f3321d15
https://pubmed.ncbi.nlm.nih.gov/29590730
https://pubmed.ncbi.nlm.nih.gov/29590730
Autor:
Alessandra, Quercioli, Fabrizio, Montecucco, Maria, Bertolotto, Luciano, Ottonello, Aldo, Pende, François, Mach, Franco, Dallegri
Publikováno v:
European Journal of Clinical Investigation; Vol 40
European Journal of Clinical Investigation, Vol. 40, No 7 (2010) pp. 645-654
European Journal of Clinical Investigation, Vol. 40, No 7 (2010) pp. 645-654
BACKGROUND: Coronary artery disease (CAD) represents the most relevant cause of death and morbidity in the adult population of developed and developing countries. During the last decades, a strong research effort has been performed to identify more s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::57387d70c2f5d5f13d40d510413c53e0
Publikováno v:
Glintborg, D, Hermann, P, Rasmussen, L M & Andersen, M 2013, ' Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome ', Journal of Endocrinological Investigation, vol. 36, no. 7, pp. 460-465 . https://doi.org/10.3275/8767
Objective Increased osteoprotegerin (OPG) levels are associated with increased cardiovascular risk and decreased bone resorption. Pioglitazone treatment reduces the inflammatory state but may decrease bone mineral density. OPG levels during pioglitaz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::857e43198d36d4aa473947c76717123f
https://portal.findresearcher.sdu.dk/da/publications/eaf1890c-5e9c-4676-aecb-94a21ede316e
https://portal.findresearcher.sdu.dk/da/publications/eaf1890c-5e9c-4676-aecb-94a21ede316e
Autor:
Cees Vermeer, Vincent Brandenburg, Michael Schoppet, Nadia Al-Fakhri, Katharina Nemeth, Claudia Goettsch, Leon J. Schurgers, Lorenz C. Hofbauer
Publikováno v:
Thrombosis and Haemostasis, 108(6), 1241-3. Georg Thieme Verlag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffedb7c646e7cb51183d5f9613d933cb
https://cris.maastrichtuniversity.nl/en/publications/111b53bb-17af-45e4-b4ec-ae6cffa04c80
https://cris.maastrichtuniversity.nl/en/publications/111b53bb-17af-45e4-b4ec-ae6cffa04c80
Autor:
Agathocles Tsatsoulis, Elissavet Hatzi, Anastasia E. Markatseli, Anna Challa, Stelios Tigas, Ioanna Bouba, Ioannis Georgiou
Publikováno v:
Maturitas. 70(2)
Wnt signaling through low-density lipoprotein receptor-related protein 5 (LRP5) is an important determinant of bone mass regulation. OBJECTIVE: To explore the influence of two LRP5 single nucleotide polymorphisms (SNPs) A1330V and V667M on bone miner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc8bc19e741fe838d2d39dd1003c812d
https://pubmed.ncbi.nlm.nih.gov/21840657
https://pubmed.ncbi.nlm.nih.gov/21840657
Autor:
Mountzios, G., Dimopoulos, M. A., Bamias, A., Papadopoulos, G., Kastritis, E., Syrigos, K., Pavlakis, G., Terpos, E.
The role of receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) system, and osteopontin (OPN) was studied in patients with solid tumors metastatic to the bone in relation to the type of malignancy and the neoplastic burde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::03c13898c1c3d5e31772630e265c1b71
http://olympias.lib.uoi.gr/jspui/handle/123456789/24174
http://olympias.lib.uoi.gr/jspui/handle/123456789/24174
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.